Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac<sup>®</sup>) in chronic immune thrombocytopenic purpuraLouis M. Aledort, O. Zenker, Benjamin Brenner et al.|Hematology|2007Cited by 12